Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress toward vector design for hematopoietic stem cell gene therapy.

R G Hawley1

  • 1Department of Hematopoiesis, Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA. hawleyr@usa.redcross.org

Current Gene Therapy
|July 12, 2002
PubMed
Summary

Hematopoietic stem cell (HSC) gene therapy shows promise for blood diseases. Advances in lentiviral vectors and gene control elements aim to improve sustained transgene expression for effective treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Co-expression of B7-1 with Interleukin-12 Enhances Vaccine-induced Antitumour Immunity in Experimental Myeloma.

Hematology (Amsterdam, Netherlands)·2016
Same author

TLX1/HOX11-induced hematopoietic differentiation blockade.

Oncogene·2007
Same author

Improved therapeutic outcome following combination immunogene vaccination therapy in murine myeloma.

Leukemia & lymphoma·2003
Same author

Identification and characterization of Magmas, a novel mitochondria-associated protein involved in granulocyte-macrophage colony-stimulating factor signal transduction.

Experimental hematology·2001
Same author

National Stem Cell Resource: stem cells find a niche.

Stem cells (Dayton, Ohio)·2001
Same author

Rhesus monkey placental transgene expression after lentiviral gene transfer into preimplantation embryos.

Proceedings of the National Academy of Sciences of the United States of America·2001

Area of Science:

  • Biomedical Engineering
  • Molecular Biology
  • Hematology

Background:

  • Hematopoietic stem cells (HSCs) are crucial for blood cell production and are ideal targets for gene therapy.
  • Gene transfer into HSCs offers potential cures for inherited and acquired blood disorders.

Purpose of the Study:

  • To review recent advances in gene transfer technologies for HSCs.
  • To discuss strategies for achieving sustained and clinically relevant transgene expression.
  • To highlight challenges and future directions in HSC gene therapy.

Main Methods:

  • Improvements in retroviral transduction protocols.
  • Development of safety-modified lentiviral vectors for HSCs.
  • Investigation of genetic control elements like insulators and scaffold/matrix attachment regions.

Related Experiment Videos

Main Results:

  • Successful amelioration of a human hematologic disease (severe combined immunodeficiency) via HSC gene transfer.
  • Lentiviral vectors show promise for transducing quiescent HSCs.
  • Ongoing research into regulatory elements to overcome transgene expression issues like position-effect variegation.

Conclusions:

  • HSC gene therapy is a rapidly advancing field with significant therapeutic potential.
  • Continued technological development is essential for realizing the full promise of HSC gene therapy.
  • Optimizing transgene expression through genetic elements will be key to clinical success.